INS and cardiovascular disorder: Promoter regulation may avoid potential complications associated with chronically high circulating levels of proinsulin such as described for cardiovascular diseases [44], [45], [46], although a recent genome-wide study found no direct association of proinsulin and coronary arterial disease pathogenesis [47].